Metronidazole USP from Canada
Metronidazole is a synthetic nitroimidazole derivative used primarily as an antibiotic for treating anaerobic bacterial and protozoal infections. It contains an unfused imidazole ring in its structure, qualifying it under HTS 2933.29.90.00 as a heterocyclic compound with nitrogen hetero-atoms only, specifically other unfused imidazole ring compounds.
Duty Rate — Canada → United States
110%
Rate breakdown
9903.04.6093.5%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.2910%Except for products described in headings 9903.05.85–9903.05.93, articles the product of Canada, as provided for in U.S. note 52 to this subchapter
Import Tips
• Provide Certificate of Analysis (COA) confirming purity meets USP standards and imidazole structure verification
• Comply with FDA import requirements including Drug Master File registration for active pharmaceutical ingredients
• Avoid misclassification as finished dosage forms which fall under Chapter 30